Literature DB >> 3235599

Determination of cotinine in urine using glass capillary gas chromatography and selective detection, with special reference to the biological monitoring of passive smoking.

G Skarping1, S Willers, M Dalene.   

Abstract

A capillary gas chromatographic (GC) method using selected-ion monitoring (SIM) was developed for the analysis of cotinine (C.A.S. No. 486-56-6) in human urine. The method is based on basic extraction of cotinine from 2 ml of urine into dichloromethane. After evaporation of the dichloromethane solution to dryness, 100 microliters of toluene were added, prior to GC-mass spectrometric (MS) analysis. Trideuterated cotinine (C.A.S. No. 97664-65-8) was used as the internal standard. More than 1000 automatic chromatographic analyses were made without column degradation. Molecular ions (M) of cotinine and trideuterated cotinine, (m/e = 176 and 179), were monitored in the electron impact (EI) mode and m/e = 177 (M + 1) and m/e = 180 (M + 1) in the chemical ionization (CI) mode with isobutane. The correlation coefficient with SIM and EI was 0.998 (5-20 ng/ml) and with CI was (0.2-2 ng/ml). For thermionic specific detection the correlation coefficient was 0.998 (10-510 ng/ml). Only capillary columns with an apolar bonded stationary phase film thickness of 1 micron showed sufficient inertness for cotinine analysis at the sub ng/ml level. The relative standard deviations for 5 and 20 ng/ml were 5.2 and 3.5% respectively (n = 12) using EI. Spiked urine samples from six non-smokers (5 ng/ml) showed a relative standard deviation of 5%. The overall recovery (25 ng/ml) was 100 +/- 4%. The minimum detectable concentration, using SIM, was ca. 2 ng/ml in the EI mode and ca. 0.2 ng/ml in the CI mode. The half-time for cotinine was ca. 18 h for both active smokers and non-smokers.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3235599     DOI: 10.1016/s0021-9673(00)88622-7

Source DB:  PubMed          Journal:  J Chromatogr


  3 in total

1.  Cytochrome P4501A2 phenotype and bladder cancer risk: The Shanghai bladder cancer study.

Authors:  Li Tao; Yong-Bing Xiang; Kenneth K Chan; Renwei Wang; Yu-Tang Gao; Mimi C Yu; Jian-Min Yuan
Journal:  Int J Cancer       Date:  2011-06-21       Impact factor: 7.396

2.  Elevated 4-aminobiphenyl and 2,6-dimethylaniline hemoglobin adducts and increased risk of bladder cancer among lifelong nonsmokers--The Shanghai Bladder Cancer Study.

Authors:  Li Tao; Billy W Day; Bibin Hu; Yong-Bing Xiang; Renwei Wang; Mariana C Stern; Manuela Gago-Dominguez; Victoria K Cortessis; David V Conti; David Van Den Berg; Malcolm C Pike; Yu-Tang Gao; Mimi C Yu; Jian-Min Yuan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-03-28       Impact factor: 4.254

3.  Changes in the relative reinforcing effects of cigarette smoking as a function of initial abstinence.

Authors:  Jin H Yoon; Stephen T Higgins; Matthew P Bradstreet; Gary J Badger; Colleen S Thomas
Journal:  Psychopharmacology (Berl)       Date:  2009-04-24       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.